Israel Ben-yoram, Director at PLURISTEM THERAPEUTICS INC (PSTI), bought 10,000 shares at $0.79 ($8K) on 2016-02-11, disclosed to the SEC on 2016-02-16.
Open-market purchase of $8k PSTI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| PSTI | BUY | 2015-09-24 | $63K | — | Filing → |
| PSTI | BUY | 2014-09-18 | $14K | — | Filing → |
| PSTI | SELL | 2014-01-21 | $161K | — | Filing → |